Antiarrhythmic effects of n-3 fatty acids: evidence from human studies

Purpose of review N-3 fatty acids from fish reduce cardiovascular mortality including sudden cardiac death. In this paper, the authors discuss the results of human studies with regard to the hypothesis that n-3 fatty acids reduce the risk of fatal coronary heart disease through antiarrhythmic effects. Recent findings Results from two recent clinical trials do not support a protective effect of n-3 fatty acids. In light of the earlier published bulk of evidence that n-3 fatty acids reduce cardiovascular mortality and sudden cardiac death, it is hard to explain these findings. Two recent observational studies confirmed that intake of n-3 fatty acids from fish is associated with less cardiovascular disease in the general population. They indicated that the protective effect of a fish meal may depend on the n-3 fatty acid content or preparation method and suggested a protective effect on arrhythmia rather than on atherosclerosis. Intervention studies on electrophysiological predictors of arrhythmia do not clearly confirm a beneficial effect of n-3 fatty acids. However, most of these studies were small or performed in healthy populations. Summary The available evidence still suggests that n-3 fatty acids may prevent fatal cardiac arrhythmia, but more conclusive studies are urgently needed.

[1]  N. Sheard Fish consumption and risk of sudden cardiac death. , 2009, Nutrition reviews.

[2]  R. Hauer,et al.  Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA , 2003, European Journal of Clinical Nutrition.

[3]  A. Evans,et al.  Fish Consumption Is Associated With Lower Heart Rates , 2003, Circulation.

[4]  A. Geelen,et al.  Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects. , 2003, American heart journal.

[5]  D. Mozaffarian,et al.  Cardiac Benefits of Fish Consumption May Depend on the Type of Fish Meal Consumed: The Cardiovascular Health Study , 2003, Circulation.

[6]  D. Mozaffarian,et al.  n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. , 2003, The American journal of clinical nutrition.

[7]  P. Elwood,et al.  Lack of benefit of dietary advice to men with angina: results of a controlled trial , 2003, European Journal of Clinical Nutrition.

[8]  A. Geelen,et al.  (N-3) fatty acids do not affect electrocardiographic characteristics of healthy men and women. , 2002, The Journal of nutrition.

[9]  P. Nestel,et al.  The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. , 2002, The American journal of clinical nutrition.

[10]  S. O'neill,et al.  Cardiac Ca(2+) regulation and the tuna fish sandwich. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[11]  D. Grobbee,et al.  Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials , 2002, Journal of hypertension.

[12]  C. Sirtori,et al.  Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. , 2002, Pharmacological research.

[13]  E. Whitley,et al.  The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART) , 2002, European Journal of Clinical Nutrition.

[14]  M. Santini,et al.  Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002, Circulation.

[15]  J. Manson,et al.  Blood levels of long-chain n-3 fatty acids and the risk of sudden death. , 2002, The New England journal of medicine.

[16]  J. Manson,et al.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. , 2002, JAMA.

[17]  L. V. van Amelsvoort,et al.  Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk in healthy volunteers. , 2002, The American journal of cardiology.

[18]  A. Leaf Prevention of Fatal Cardiac Arrhythmias by Polyunsaturated Fatty Acids , 2002, Nutrition and health.

[19]  E. Schmidt,et al.  Heart rate variability and n‐3 polyunsaturated fatty acids in patients with diabetes mellitus , 2001, Journal of internal medicine.

[20]  W. Leifert,et al.  Dietary fish oil prevents asynchronous contractility and alters Ca(2+) handling in adult rat cardiomyocytes. , 2001, The Journal of nutritional biochemistry.

[21]  C Guérot,et al.  Resting heart rate as a predictive risk factor for sudden death in middle-aged men. , 2001, Cardiovascular research.

[22]  E. Toft,et al.  Marine n-3 Fatty Acids, Wine Intake, and Heart Rate Variability in Patients Referred for Coronary Angiography , 2001, Circulation.

[23]  X. Jouven,et al.  Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations , 2000 .

[24]  D. Saint,et al.  Inhibition of cardiac sodium currents in adult rat myocytes by n‐3 polyunsaturated fatty acids , 1999, The Journal of physiology.

[25]  J. Charnock Omega-3 polyunsaturated fatty acids and ventricular fibrillation: the possible involvement of eicosanoids. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.

[26]  E. Schmidt,et al.  Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. , 1999, The American journal of clinical nutrition.

[27]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[28]  M. Franzosi,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[29]  T. Mori,et al.  Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. , 1999, Hypertension.

[30]  M. Grønbæk,et al.  Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies , 1999, European Journal of Clinical Nutrition.

[31]  A. Macknight,et al.  Effects of eicosapentaenoic acid on the contraction of intact, and spontaneous contraction of chemically permeabilized mammalian ventricular myocytes. , 1999, Journal of molecular and cellular cardiology.

[32]  J. Hansen,et al.  Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. , 1998, The American journal of clinical nutrition.

[33]  T Seppänen,et al.  Power-law relationship of heart rate variability as a predictor of mortality in the elderly. , 1998, Circulation.

[34]  A. Leaf,et al.  Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[36]  H. Kornerup,et al.  Heart rate variability and n-3 fatty acids in patients with chronic renal failure--a pilot study. , 1998, Clinical nephrology.

[37]  J. Manson,et al.  Fish consumption and risk of sudden cardiac death. , 1998, JAMA.

[38]  V. Rastogi,et al.  Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival—4 , 1997, Cardiovascular Drugs and Therapy.

[39]  E Toft,et al.  Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. , 1997, The American journal of cardiology.

[40]  W. Lederer,et al.  Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Leaf,et al.  Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Egon Toft,et al.  Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial , 1996, BMJ.

[43]  A. Leaf,et al.  Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  T. Raghunathan,et al.  Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. , 1995, JAMA.

[45]  P. Weber,et al.  Effects of dietary fish oil on ventricular premature complexes. , 1995, The American journal of cardiology.

[46]  Ferdinand J. Venditti,et al.  Reduced Heart Rate Variability and Mortalit Risk in an Elderly Cohort: The Framingham Heart Study , 1994, Circulation.

[47]  L. Tavazzi,et al.  Prevalence and Prognostic Significance of Ventricular Arrhythmias After Acute Myocardial Infarction in the Fibrinolytic Era GISSI‐2 Results , 1993, Circulation.

[48]  A J Camm,et al.  Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. , 1992, British heart journal.

[49]  A. Camm,et al.  Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. , 1991, Journal of the American College of Cardiology.

[50]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[51]  T. Hayakawa,et al.  Plasma plasmalogens of the phosphoethanolamine type and angiopathy in diabetic patients , 1990, Klinische Wochenschrift.

[52]  P. Elwood,et al.  EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.

[53]  A. Kristinsson,et al.  Cod liver oil does not reduce ventricular extrasystoles after myocardial infarction , 1989, Journal of internal medicine.

[54]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[55]  H. Sewell,et al.  CYTOCHROME P-450 IMMUNOLOCALISATION IN HUMAN LIVER , 1986, The Lancet.

[56]  D Kromhout,et al.  The inverse relation between fish consumption and 20-year mortality from coronary heart disease. , 1985, The New England journal of medicine.

[57]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.

[58]  G. Pickering,et al.  Reflex Regulation of Arterial Pressure during Sleep in Man: A Quantitative Method of Assessing Baroreflex Sensitivity , 1969, Circulation research.

[59]  M. Malik Heart Rate Variability and Baroreflex Sensitivity , 2004 .

[60]  T. Ashley Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. , 2001, Journal of insurance medicine.

[61]  P. McLennan,et al.  Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models , 2001, Lipids.

[62]  W. Harris,et al.  n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.

[63]  K. Rasmussen,et al.  n-3 fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias , 1995 .

[64]  H. Vetter,et al.  Fish oil and baroreceptor function in man. , 1990, Klinische Wochenschrift.